Trial Profile
An Open-Label Study to Assess the Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 30 Oct 2019
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors IMPAX Laboratories
- 06 Apr 2009 New trial record